Cytokine receptors and signaling in hepatic stellate cells

Seminars in Liver Disease

Volumn 21, Issue 3, 2001, Pages 397-416

  Pinzani, M ^a   Marra, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cytokine receptors; Cytokine signaling; Hepatic stellate cells; Liver tissue damage

Indexed keywords

ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE RECEPTOR; ENDOTHELIN 1; GAMMA INTERFERON; GROWTH FACTOR RECEPTOR; INTERLEUKIN 10; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; THROMBIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; VASOPRESSIN;

ANIMAL CELL; CHRONIC LIVER DISEASE; EXTRACELLULAR MATRIX; FIBROGENESIS; HUMAN; HUMAN CELL; INFLAMMATION; LIVER CELL; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL;

CYTOKINES; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; OXIDATIVE STRESS; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION;

EID: 0034810089     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17554     Document Type: Review

References (171)

1. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
2. Liver fibrosis
3. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fatstoring cells
4. Regulation of macrophage-colony stimulating factor in liver fatstoring cells by peptide growth factors
5. Transforming growth factor-w1 regulates platelet-derived growth factor subunit in human liver fat-storing cells
6. Expression of platelet-derived growth factor in a model of acute liver injury
7. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis
8. Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats
9. PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury
10. Platelet-derived receptor signals
11. Modular binding domain in signal transduction proteins
12. Protein modules and signalling networks
13. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
14. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase
15. MAPK are required for fibroblast proliferation
16. Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells
17. Interferon-γ-mediated activation of STAT1α regulates growth factor-induced mitogenesis
18. ERK activation differentially regulates PDGF's actions in hepatic stellate cells, and is induced by in vivo liver injury
19. The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cells
20. Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells
21. Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors
22. Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells
23. Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: A cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors
24. Inhibition of the EGF-activated MAP kinase signalling pathway by adenosine 3′,5′-monophosphate
25. Protein kinase A antagonizes platelet-derived growth factor-induced signalling by mitogen-activated protein kinase in human arterial smooth muscle cells
26. Regulation by cAMP of STAT1 activation in hepatic stellate cells
27. Phosphatidylinositol 3-kinase: A novel effector
28. Phospholipase C-gamma and phosphatidylinositol 3-kinase are the downstream mediators of the PDGF receptor's mitogenic signal
29. Regulation of chemotaxis by platelet-derived growth factor receptor beta
30. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells
31. Phosphatidyli-nositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells
32. Insulin-like growth factor I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation
33. Apoptosis of hepatic stellate cells: Involvement in resolution of biliary fibrosis and regulation by soluble growth factors
34. Cellular survival: A play in three Akts
35. IGF-I is a survival factor for human hepatic stellate cells (HSC): Involvement of PI3-K and c-Akt
36. Growth-factor-dependent mitogenesis requires two distinct phases of signalling
37. PDGF induces an early and late wave of PI3-kinase activity, and only the late wave is required for progression trough G1
38. Signal transduction by the chemokine receptor CXCR3. Activation of Ras/ERK, Src and PI 3-K/Akt controls cell migration and proliferation in human vascular pericytes
39. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells
40. Differing signal transduction elicited by three isoforms of platelet-derived growth factor in vascular smooth muscle cells
41. 2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts
42. The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx
43. 2+ channel activation by platelet-derived growth factor-induced tyrosine phosphorylation and Ras guanine triphosphate-binding proteins in rat glomerular mesangial cells
44. Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells
45. Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells
46. + exchange activation by platelet-derived growth factor in rat hepatic stellate cells
47. + exchange activity in human hepatic stellate cells: Effects of platelet-derived growth factor, insulin-like growth factor 1 and insulin
48. + exchanger reduces rat hepatic stellate cell activity and liver fibrosis: An in vitro and in vivo study
49. + exchanger in hepatic stellate cells (HSC): Effect of canrenone
50. HNE interacts directly with JNK isoforms in human hepatic stellate cells
51. Interaction between 4-hydroxy-2,3-alkenals and the PDGF-β receptor. Reduced tyrosine phosphorylation and downstream signaling in hepatic stellate cells
52. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor
53. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis
54. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): An insight into an intracrine mechanism
55. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
56. Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis
57. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing
58. Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1
59. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells
60. TGF-β and fibrosis
61. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation
62. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis
63. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy
64. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions
65. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
66. Cytokines and fibrogenesis
67. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells. A potential mechanism of self perpetuation in liver fibrogenesis
68. Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells
69. Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: Evidence for mediation by endogenous platelet-derived growth factor
70. Specificity, diversity, and regulation in TGF-beta superfamily signaling
71. How cells read TGF-beta signals
72. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
73. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta
74. Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo
75. Role of transforming growth factor beta type II receptor in hepatic fibrosis: Studies of human chronic hepatitis C and experimental fibrosis in rats
76. TGF-β signal transduction
77. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts
78. Suppressors of transforming growth factor-beta pathway mutants in the Caenorhabditis elegans dauer formation pathway
79. Transforming growth factorbeta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site
80. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription
81. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells
82. Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells
83. Raf and mitogen-activated protein kinase regulate stellate cell collagen gene expression
84. Activation by acetaldehyde of the promoter of the mouse alpha2(I) collagen gene when transfected into rat activated stellate cells
85. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression
86. Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells
87. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells
88. Expression of activin A is increased in cirrhotic and fibrotic rat livers
89. Endothelin, a novel endothelium-derived peptide
90. Endothelins: A family of regulatory peptides
91. Endothelins: Multifunctional renal peptides
92. Structural basis of the function of endothelin receptor
93. Endothelin, a potent peptide agonist in the liver
94. EndotheIin-1-stimulated glucose production in vitro in the isolated perfused rat liver
95. Regulation of endothelin-1 action on the perfused rat liver
96. Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes
97. 2+ oscillations, and activation of glycogenolysis
98. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells
99. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites
100. Overexpression of endothelin-1 in bile duct ligated rats: Correlation with activation of hepatic stellate cells and portal pressure
101. Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells
102. Gene expression of endothelin-1 and ET(A) and ET(B) receptors in human cirrhosis: Relationship with hepatic hemodynamics
103. Sinusoidal endothelial liver cells in vitro release endothelin: Augmentation by transforming growth factor β and Kupffer cell-conditioned media
104. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1
105. Superoxide-induced changes in endothelin (ET) receptors in hepatic stellate cells
106. Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing
107. Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1
108. Endothelin stimulates mitogen-activated protein kinase activity in mesangial cells through ET(A)
109. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells: An endothelin B receptor-mediated pathway
110. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2
111. Down-regulation of endothelin receptors by transforming growth factor beta1 in hepatic stellate cells
112. Endotoxin causes upregulation of endothelin receptors in cultured hepatic stellate cells via nitric oxide-dependent and -independent mechanisms
113. Fat-storing cells as liver-specific pericytes: Spatial dynamics of agonist-stimulated intracellular calcium transients
114. Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rho-kinase-mediated alterations in the acto-myosin cytoskeleton
115. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing
116. Chronic blockade of endothelin receptors in cirrhotic rats: Hepatic and hemodynamic effects
117. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis
118. Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes
119. Angiotensin II induces contraction and proliferation of human hepatic stellate cells
120. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy
121. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells
122. Thrombin signalling and protease-activated receptors
123. Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: Potential role in liver injury
124. Expression of the thrombin receptor in human liver: Up-regulation during acute and chronic injury
125. Biosynthesis of platelet-activating factor and its 10-acyl analogue by liver fat-storing cells
126. The biology of chemokines and their receptors
127. Hepatic stellate cells and the regulation of liver inflammation
128. Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis
129. Chemokines and disease
130. CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines
131. Death receptors: Signaling and modulation
132. Recent advances in the molecular basis of TNF signal transduction
133. Mice lacking the tumour necrosis factor receptor-1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
134. Effect of turnout necrosis factor-alpha on proliferation, activation and protein synthesis of rat hepatic stellate cells
135. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells
136. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2
137. Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells
138. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells
139. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins
140. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
141. Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells
142. Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture
143. Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells
144. Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein
145. TNF-alpha inhibits liver collagen-alpha 1(I) gene expression through a tissue-specific regulatory region
146. Tumor necrosis factor alpha down-regulates expression of the alpha1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPbeta- and C/EBPdelta-dependent mechanism
147. Collagen alpha1(I) gene contains an element responsive to tumor necrosis factor-alpha located in the 5′ untranslated region of its first exon
148. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair
149. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand
150. Hepatic stellate cells express the low affinity, nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation
151. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors
152. CD40 activates NF-kappaB and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells
153. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells
154. An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver
155. STATs and gene regulation
156. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility
157. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: Regulation by cytokines
158. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture
159. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis
160. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis
161. Effects of murine recombinant interferon-gamma on rat liver fat storing cell proliferation, cluster formation and proteoglycan synthesis
162. Induction of an acute phase response in rats stimulates the expression of alpha1(I) procollagen messenger ribonucleic acid in their livers. Possible role of interleukin-6
163. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells
164. Oncostatin M: A cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells
165. Expression and function of integrins receptors for collagen and laminin in cultured human hepatic stellate cells
166. The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture
167. Tyrosine phosphorylation of paxillin and pp125 FAK accompanies cell adhesion to extracellular matrix: A role in cytoskeletal assembly
168. Focal adhesion kinase: An integrin-linked protein tyrosine kinase
169. Focal adhesion kinase and paxillin bind to peptides mimicking β integrin cytoplasmic domains
170. Focal adhesion kinase and phospholipase Cγ involvement in adhesion and migration of human hepatic stellate cells
171. The structural and mechanical complexity of cell-growth control